Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAS181 in parainfluenza infection
NCT01441024Phase 2Withdrawn
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jul 2011
- Primary completion
- Feb 2014
- Modality
- Fc-Fusion Proteins
01
Overview
A Phase 2 trial of DAS181 in parainfluenza virus infection, sponsored by National Institute of Allergy and Infectious Diseases. Planned start Jul 2011; status: withdrawn.
02
Drugs
DAS181
03
Conditions
parainfluenza virus infection
Beyond the preview
Go deeper on NCT01441024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01441024.